April 2019
Read More
Consultation responses
Implementing the NHS LTP proposals for legislative change consultation response
Response to cannabis guideline scope consultation
4 December 2018
NICE is currently scoping a new guideline on cannabis based products for medicinal use. The Neurological Alliance responded to the consultation.
Read More
Impact of a no deal Brexit consultation response
16 October 2018
The Health and Social Care Select Committee held an inquiry into the impact of a no-deal Brexit on health and social care during 2018.
Read More
Neurological Alliance response to draft neurosurgery specification
18 September 2018
The Neurological Alliance response to NHS England’s consultation on the neurosurgery service specification.
Read More
Neurological Alliance response to neurosciences review engagement
15 September 2018
NHS England is currently at the early stages of reviewing specialised neuroscience services. Following a scoping event with patient groups in September 2018,
Read More
Suspected Neurological Conditions in Primary Care NICE consultation response
September 2017
The Neurological Alliance response to the NICE consultation on a new guideline on suspected neurological conditions.
Read More
NHS England Generic Commissioning Policies Consultation
23 January 2017
This consultation response covers the NHS England consultation exercises on four proposed generic commissioning policies:
1 In-year service developments
2 Individual Funding Requests
3 Funding for experimental and unproven treatments
4 Continuing funding after clinical trials
Read More
NHS England Investment Prioritisation Consultation
12 May 2016
The Neurological Alliance submitted a response to NHS England’s consultation on the proposed process for prioritising investments in new specialised treatments and products.
Read More
Neurological Alliance’s comments on the Government’s response to the Public Account’s Committee’s progress review
12 May 2016
This document sets out the Neurological Alliance’s comments on the Department of Health’s response to the Public Accounts Committee report,
Read More